Uterine fibroids may play a protecting role against endometrial carcinoma in Chinese women with gynecological diseases

Biosci Rep. 2020 Jul 31;40(7):BSR20200350. doi: 10.1042/BSR20200350.

Abstract

Background: It has been reported that uterine fibroids (UFs) may increase the risk of endometrial carcinoma (EC) with the underlying mechanism largely unknown. Here, we explore whether UF could be an influential factor for EC.

Methods: We have collected and analyzed clinical data from 4537 Chinese patients to study the co-incidence of UF and EC. Then, a large-scale literature-based data mining was conducted to identify genes implicated as UF downstream regulating targets and EC upstream regulators. In addition, a meta-analysis has been conducted for each of the EC-specific genes, using six independent UF expression datasets. The meta-analysis results, together with literature-based pathway analysis, were used to explore the potential explanation of the clinical data.

Results: Our results showed that the incidence rate of EC in the case of UF was 50.53% lower than without UF, which suggested a protective role of UF in EC patients. The meta-analysis identified three significantly overexpressed genes (HTRA3, HOPX, and PCNA) in the case of UF, which were implicated as EC inhibitors in the pathway analysis. Multiple linear regression (MLR) analysis showed that, compared with UF, aging might be a stronger influential factor for EC.

Conclusion: Among women with gynecological diseases, UFs may play a protecting role against EC in the Chinese population.

Keywords: HOPX; HTRA3; PCNA; Uterine fibroids; endometrial carcinoma; mega-analysis.

Publication types

  • Meta-Analysis

MeSH terms

  • Adult
  • Age Factors
  • Case-Control Studies
  • China / epidemiology
  • Datasets as Topic
  • Endometrial Neoplasms / diagnosis
  • Endometrial Neoplasms / epidemiology*
  • Endometrial Neoplasms / genetics
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Homeodomain Proteins / genetics
  • Humans
  • Incidence
  • Leiomyoma / diagnosis
  • Leiomyoma / epidemiology*
  • Leiomyoma / genetics
  • Middle Aged
  • Proliferating Cell Nuclear Antigen / genetics
  • Protective Factors
  • Risk Factors
  • Serine Endopeptidases / genetics
  • Tumor Suppressor Proteins / genetics
  • Ultrasonography, Doppler, Color
  • Uterus / diagnostic imaging
  • Young Adult

Substances

  • HOPX protein, human
  • Homeodomain Proteins
  • PCNA protein, human
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Proteins
  • HTRA3 protein, human
  • Serine Endopeptidases